National Medical Care Company (4005.SR) — Cash flow
Operating, investing, and financing cash flow for National Medical Care Company — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | 318↑8.3% | 294↑21.9% | 241↑21.4% | 199↑20.7% | 164 | |
| Depreciation & Amortization | 0.00↓100.0% | 80↑46.5% | 55↑20.2% | 46↓8.9% | 50 | |
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stock-Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes in Working Capital | -327↓236.7% | -97↓152.4% | 185↑888.5% | -23↑86.6% | -175 | |
| Accounts Receivable | -298↓321.6% | -71↓136.7% | 193↑569.8% | -41↑79.4% | -199 | |
| Inventory | -7↓824.8% | -0.72↑90.6% | -8↓339.9% | 3↑33660.4% | -0.01 | |
| Accounts Payable | -10↑61.6% | -26↑7.1% | -28↓292.5% | 14↓41.2% | 24 | |
| Other Working Capital | -12↑0.5% | -12↓145.1% | 28↑287.9% | -15↑3.6% | -15 | |
| Other Non-Cash Items | 162↑601.1% | -32↓125.6% | -14↓273.0% | -4↓107.1% | 54 | |
| Net Cash from Operating Activities | 153↓37.5% | 245↓47.6% | 467↑115.2% | 217↑131.2% | 94 | |
| Operating Cash Flow | 153↓37.5% | 245↓47.6% | 467↑115.2% | 217↑131.2% | 94 | |
| Investing Activities | ||||||
| Investment in Property, Plant & Equipment | -131↑47.5% | -250↓362.4% | -54↑74.5% | -212↓417.6% | -41 | |
| Capital Expenditure | -131↑47.9% | -251↓360.4% | -55↑74.2% | -212↓417.6% | -41 | |
| Acquisitions | 0.00↑100.0% | -23↑87.3% | -185↓827303.0% | 0.02↓88.8% | 0.20 | |
| Purchases of Investments | 0.00 | 0.00↑100.0% | -385 | 0.00 | 0.00 | |
| Sales & Maturities of Investments | 0.00↓100.0% | 82 | 0.00 | 0.00 | 0.00 | |
| Other Investing Activities | 252↑17539.4% | -1↓158.2% | -0.56↑99.7% | -181↓2018.2% | -9 | |
| Net Cash from Investing Activities | 121↑162.8% | -193↑69.2% | -625↓195.1% | -212↓420.1% | -41 | |
| Financing Activities | ||||||
| Net Debt Issuance | 45↑39.8% | 32↓82.7% | 185↑3209.1% | -6↓0.0% | -6 | |
| Long-Term Net Debt Issuance | 45↑39.8% | 32↓82.7% | 185↑3209.1% | -6↓0.0% | -6 | |
| Short-Term Net Debt Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Stock Issuance | 0.00↑100.0% | -34 | 0.00 | 0.00 | 0.00 | |
| Net Common Stock Issuance | 0.00↑100.0% | -34 | 0.00 | 0.00 | 0.00 | |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Share Buybacks | 0.00↑100.0% | -34 | 0.00 | 0.00 | 0.00 | |
| Net Preferred Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | -89↑0.4% | -90↓100.0% | -45↑0.0% | -45↑0.0% | -45 | |
| Common Dividends Paid | -89↑0.4% | -90↓100.0% | -45↑0.0% | -45↑0.0% | -45 | |
| Preferred Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | -14↓179.8% | -5↓129.0% | -2 | 0.00 | 0.00 | |
| Net Cash from Financing Activities | -59↑39.1% | -97↓170.4% | 138↑371.0% | -51↓0.0% | -51 | |
| Cash Reconciliation | ||||||
| Effect of Foreign Exchange | -479 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Change in Cash | -264↓488.3% | -45↓118.3% | -21↑55.1% | -46↓2099.9% | 2 | |
| Cash at Beginning of Period | 264↓14.5% | 309↓6.2% | 329↓12.2% | 375↑0.6% | 373 | |
| Cash at End of Period | 0.00↓100.0% | 264↓14.5% | 309↓6.2% | 329↓12.2% | 375 | |
| Income Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | 22↑434.3% | -7↓101.6% | 412↑8104.8% | 5↓90.5% | 53 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.